Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $54.75 and last traded at $54.70, with a volume of 2168 shares changing hands. The stock had previously closed at $54.06.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada upgraded shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a report on Friday, May 2nd.
View Our Latest Research Report on Sandoz Group
Sandoz Group Stock Up 1.8%
The company has a quick ratio of 0.79, a current ratio of 1.24 and a debt-to-equity ratio of 0.57. The firm's 50 day simple moving average is $50.42 and its two-hundred day simple moving average is $45.76.
Sandoz Group Company Profile
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
